Cargando…

Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study

Background and Aim: Real world evidence on long term treatment of patients with familial hypercholesterolemia (FH) is important. We studied the effects of intensive lipid lowering medication (LLM) and optimized lifestyle in the study TTTFH–Treat To Target FH. Materials and Methods: Adults with a fir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arnesen, Kjell-Erik, Phung, Ann Vinh, Randsborg, Karoline, Mork, Irene, Thorvall, Marlene, Langslet, Gisle, Svilaas, Arne, Wium, Cecilie, Ose, Leiv, Retterstøl, Kjetil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961401/ https://www.ncbi.nlm.nih.gov/pubmed/33737874 http://dx.doi.org/10.3389/fphar.2020.560958

Ejemplares similares

Data on circulating leukocyte subpopulations and inflammatory proteins in children with familial hypercholesterolemia and healthy children
por: Christensen, Jacob J., et al.
Publicado: (2016)

Thirty percent of children and young adults with familial hypercholesterolemia treated with statins have adherence issues
por: Langslet, Gisle, et al.
Publicado: (2021)

Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
por: Molven, Ingunn, et al.
Publicado: (2013)

Young women with familial hypercholesterolemia have higher LDL-cholesterol burden than men: Novel data using repeated measurements during 12-years follow-up
por: Johansen, Anja K., et al.
Publicado: (2023)

Mortality Among Patients With Familial Hypercholesterolemia: A Registry‐Based Study in Norway, 1992–2010
por: Mundal, Liv, et al.
Publicado: (2014)

Secular trends in serum lipid profiles in young adults in Norway, 2001-19
por: Arnesen, Erik Kristoffer, et al.
Publicado: (2022)

Saturated fat –a never ending story?
por: Svendsen, Karianne, et al.
Publicado: (2017)

Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study
por: Langslet, Gisle, et al.
Publicado: (2020)

Association of Familial Hypercholesterolemia and Statin Use With Risk of Dementia in Norway
por: Mundal, Liv J., et al.
Publicado: (2022)

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
por: Kastelein, John J. P., et al.
Publicado: (2014)

An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia
por: Gandelman, Kuan, et al.
Publicado: (2011)

The heart failure burden of type 2 diabetes mellitus—a review of pathophysiology and interventions
por: Ofstad, Anne Pernille, et al.
Publicado: (2018)

The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review
por: Hovland, Anders, et al.
Publicado: (2022)

Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management
por: Mytilinaiou, Maria, et al.
Publicado: (2018)

Subjects with Low Plasma HDL Cholesterol Levels Are Characterized by an Inflammatory and Oxidative Phenotype
por: Holven, Kirsten B., et al.
Publicado: (2013)

Lower risk of smoking-related cancer in individuals with familial hypercholesterolemia compared with controls: a prospective matched cohort study
por: Krogh, Henriette W., et al.
Publicado: (2019)

Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia
por: Mundal, Liv J, et al.
Publicado: (2018)

Oral Unsaturated Fat Load Impairs Postprandial Systemic Inflammation in Primary Hypercholesterolemia Patients
por: Collado, Aida, et al.
Publicado: (2021)

Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)
por: Langslet, Gisle, et al.
Publicado: (2020)

Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin
por: Leiter, Lawrence A., et al.
Publicado: (2016)

The Real Code of Leonardo da Vinci
por: Ose, Leiv
Publicado: (2008)

Intermittent Fasting Inhibits High-Fat Diet–Induced Atherosclerosis by Ameliorating Hypercholesterolemia and Reducing Monocyte Chemoattraction
por: Chen, Yuanli, et al.
Publicado: (2021)

Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study
por: Toth, Peter P., et al.
Publicado: (2016)

MicroRNA-33b is a Potential Non-Invasive Biomarker for Response to Atorvastatin Treatment in Chilean Subjects With Hypercholesterolemia: A Pilot Study
por: Ubilla, Carmen Gloria, et al.
Publicado: (2021)

Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors as Adjuvant Treatments for Patients with Hypercholesterolemia Treated with Statin: A Systematic Review and Network Meta-analysis
por: Huang, Yi-Ting, et al.
Publicado: (2022)

Characteristics of Glucose Metabolism in Nordic and South Asian Subjects with Type 2 Diabetes
por: Wium, Cecilie, et al.
Publicado: (2013)

The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results
por: Al-Rasadi, Khalid, et al.
Publicado: (2020)

The Blind Spot of Pharmacology: A Scoping Review of Drug Metabolism in Prematurely Born Children
por: Mørk, Mette Louise, et al.
Publicado: (2022)

Targeting protein–protein interactions in complexes organized by A kinase anchoring proteins
por: Calejo, Ana I., et al.
Publicado: (2015)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Spatiotemporal regulation of cAMP signaling controls the human trophoblast fusion
por: Gerbaud, Pascale, et al.
Publicado: (2015)

Antidepressant Effects of NSAIDs in Rodent Models of Depression—A Systematic Review
por: Bay-Richter, Cecilie, et al.
Publicado: (2022)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro
por: Halvorsen, Bente, et al.
Publicado: (2016)

Molecular Integration in Adenosine Heteroreceptor Complexes Through Allosteric and De-Phosphorylation (STEP) Mechanisms and its Role in Brain Disease
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2022)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis
por: Ren, Lu, et al.
Publicado: (2020)

Editorial: “Purinergic Signaling 2020: The State-of-The-Art Commented by the Members of the Italian Purine Club”
por: Ciruela, Francisco, et al.
Publicado: (2021)

Development and validation of a new non-disease-specific survey tool to assess self-reported adherence to medication
por: Larsen, Rønnaug Eline, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m8lefg1evd47jujjs0rv7rp8d9